Natasa Popovic, MD | |
2081 Forest Ave Ste 1, San Jose, CA 95128-4841 | |
(408) 294-2399 | |
(408) 294-1753 |
Full Name | Natasa Popovic |
---|---|
Gender | Female |
Speciality | Hospitalist |
Experience | 35 Years |
Location | 2081 Forest Ave Ste 1, San Jose, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831225713 | NPI | - | NPPES |
A96234 | Other | CA | MEDICAL DOCTOR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | A96234 (California) | Secondary |
207R00000X | Internal Medicine | A96234 (California) | Secondary |
208M00000X | Hospitalist | A96234 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hermann Hospital System | Houston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
The Washington Post on Tuesday examined how Pennsylvania's Geisinger Health System has successfully improved outcomes for elective heart surgery patients through its 90-day warranty program, which charges a flat fee covering the cost of the procedure and any needed follow-up care. Geisinger operates its own insurance plan and has 41 clinics, three hospitals and 650 staff physicians.
Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
Medicare Advantage enrollees should make a habit of evaluating their options each year. Though experts say that beneficiaries won't be seeing a lot of changes this time and what changes there are will mostly be for the better it is a good idea for people to go through this annual drill before enrollment ends Dec. 31, just to make sure their plan choice remains a good one.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Robert Schroth, University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada, will present a study titled "Microbiome Associated With Severe Caries in Canadian First Nations Children." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
› Verified 3 days ago
Entity Name | Memorial Hermann Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
The Washington Post on Tuesday examined how Pennsylvania's Geisinger Health System has successfully improved outcomes for elective heart surgery patients through its 90-day warranty program, which charges a flat fee covering the cost of the procedure and any needed follow-up care. Geisinger operates its own insurance plan and has 41 clinics, three hospitals and 650 staff physicians.
Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
Medicare Advantage enrollees should make a habit of evaluating their options each year. Though experts say that beneficiaries won't be seeing a lot of changes this time and what changes there are will mostly be for the better it is a good idea for people to go through this annual drill before enrollment ends Dec. 31, just to make sure their plan choice remains a good one.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Robert Schroth, University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada, will present a study titled "Microbiome Associated With Severe Caries in Canadian First Nations Children." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Natasa Popovic, MD 2081 Forest Ave Ste 1, San Jose, CA 95128-4841 Ph: (408) 294-2399 | Natasa Popovic, MD 2081 Forest Ave Ste 1, San Jose, CA 95128-4841 Ph: (408) 294-2399 |
News Archive
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
The Washington Post on Tuesday examined how Pennsylvania's Geisinger Health System has successfully improved outcomes for elective heart surgery patients through its 90-day warranty program, which charges a flat fee covering the cost of the procedure and any needed follow-up care. Geisinger operates its own insurance plan and has 41 clinics, three hospitals and 650 staff physicians.
Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
Medicare Advantage enrollees should make a habit of evaluating their options each year. Though experts say that beneficiaries won't be seeing a lot of changes this time and what changes there are will mostly be for the better it is a good idea for people to go through this annual drill before enrollment ends Dec. 31, just to make sure their plan choice remains a good one.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Robert Schroth, University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada, will present a study titled "Microbiome Associated With Severe Caries in Canadian First Nations Children." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
› Verified 3 days ago
Trupti Y. Kapadia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Kent Yu Feng, Hospitalist Medicare: Medicare Enrolled Practice Location: 751 S Bascom Ave, San Jose, CA 95128 Phone: 408-885-5611 | |
Hemali A. Sudhalkar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Albert S. Lau, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Kelly Louis Crawford, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Leo Ramek, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 | |
Y. L. Pham, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 |